Top Bulls Reasons To Buy — Vote below!

100%
agree
very bullies

Add a New Bulls Reason

Company: GENETIC TECHNOLOGIES (GENE)
Current price:
Headline: (100 character max)
Analysis:
Cancel
100%
agree
2 votes

  very bullies

Company announced to launch BREVAGen™- world’s first validated test for non-familial breast cancer in the first quarter 2011. cancer prognostic test in this quarter with a U.S> market target of 1 million patients per annum.

The Company has identified three target markets for its test: BRCA negative patients, breast biopsy patients and women over 35 having a family history of cancer.

The test combines population risk factors with genetic risk factors to give integrated individual breast cancer risk assessment. BREVAGen test also informs personalized clinical decision support for non-familial risk of breast cancer and is the first fully peer reviewed validated test of its kind.

The Company had through references estimated that the U.S. market for existing breast cancer molecular diagnostics was about $690 million in 2006 and has grown at almost 18% CAGR since.

The Company identifies BREVAGen to have an attractive CoGS, ROI and payback with a large, characterized and global market.

Genetic Technologies Limited is engaged in a diagnostic product business. The Company translates genetic tests into products and services. The Company’s cancer diagnostics business focused on building a sustainable stable of products and services.

(100 character max) Cancel
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki